|
||||||
Executive Summary AnaptysBio, Inc.-Product Pipeline Review-2015 Summary Global Markets Direct's, 'AnaptysBio, Inc.-Product Pipeline Review-2015', provides an overview of the AnaptysBio, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of AnaptysBio, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides brief overview of AnaptysBio, Inc. including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of AnaptysBio, Inc.'s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the AnaptysBio, Inc.'s pipeline products Reasons To Buy Evaluate AnaptysBio, Inc.'s strategic position with total access to detailed information on its product pipeline Assess the growth potential of AnaptysBio, Inc. in its therapy areas of focus Identify new drug targets and therapeutic classes in the AnaptysBio, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of AnaptysBio, Inc. and exploit collaboration and partnership opportunities Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying the most promising pipeline of AnaptysBio, Inc. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of AnaptysBio, Inc. and identify potential opportunities in those areas Avoid Intellectual Property Rights related issues Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 AnaptysBio, Inc. Snapshot 4 AnaptysBio, Inc. Overview 4 Key Information 4 Key Facts 4 AnaptysBio, Inc.-Research and Development Overview 5 Key Therapeutic Areas 5 AnaptysBio, Inc.-Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products-Monotherapy 8 Pipeline Products-Partnered Products 9 Partnered Products/Combination Treatment Modalities 10 Pipeline Products-Out-Licensed Products 11 Out-Licensed Products/Combination Treatment Modalities 12 AnaptysBio, Inc.-Pipeline Products Glance 13 AnaptysBio, Inc.-Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 AnaptysBio, Inc.-Drug Profiles 14 ANB-004 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 ANB-020 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Monoclonal Antibody for Idiopathic Pulmonary Fibrosis 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 AnaptysBio, Inc.-Pipeline Analysis 17 AnaptysBio, Inc.-Pipeline Products by Target 17 AnaptysBio, Inc.-Pipeline Products by Molecule Type 18 AnaptysBio, Inc.-Pipeline Products by Mechanism of Action 19 AnaptysBio, Inc.-Recent Pipeline Updates 20 AnaptysBio, Inc.-Dormant Projects 21 AnaptysBio, Inc.-Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 23 Disclaimer 24 List of Tables AnaptysBio, Inc., Key Information 4 AnaptysBio, Inc., Key Facts 4 AnaptysBio, Inc.-Pipeline by Indication, 2015 6 AnaptysBio, Inc.-Pipeline by Stage of Development, 2015 7 AnaptysBio, Inc.-Monotherapy Products in Pipeline, 2015 8 AnaptysBio, Inc.-Partnered Products in Pipeline, 2015 9 AnaptysBio, Inc.-Partnered Products/ Combination Treatment Modalities, 2015 10 AnaptysBio, Inc.-Out-Licensed Products in Pipeline, 2015 11 AnaptysBio, Inc.-Out-Licensed Products/ Combination Treatment Modalities, 2015 12 AnaptysBio, Inc.-Preclinical, 2015 13 AnaptysBio, Inc.-Pipeline by Target, 2015 17 AnaptysBio, Inc.-Pipeline by Molecule Type, 2015 18 AnaptysBio, Inc.-Pipeline Products by Mechanism of Action, 2015 19 AnaptysBio, Inc.-Recent Pipeline Updates, 2015 20 AnaptysBio, Inc.-Dormant Developmental Projects,2015 21 List of Figures AnaptysBio, Inc.-Pipeline by Top 10 Indication, 2015 6 AnaptysBio, Inc.-Out-Licensed Products in Pipeline, 2015 11 AnaptysBio, Inc.-Pipeline by Top 10 Target, 2015 17 AnaptysBio, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 19 Single User License: Site License: Corporate User License: Current R&D Portfolio of AnaptysBio, Inc.; AnaptysBio, Inc. - Key Therapeutics; AnaptysBio, Inc. - Pipeline Overview and Promising Molecules; AnaptysBio, Inc. - News; AnaptysBio, Inc. - Latest Updates; AnaptysBio, Inc. - Pipeline; AnaptysBio, Inc. - Discontinued/Dormant Projects |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center" |